Roche Holding said its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, bolstering the Swiss drugmaker’s defense against a wave of cut-price competition to its top-selling medicines.

Sections:  world   
Topics:  europe   
  • Roche's (RHHBY) Sales Grow Y/Y in 1H17 on New Drug Launches
    Roche continues to expand cancer immunotherapy drug Tecentriq (bladder and lung cancer)'s label ... Roche also presented positive results on emicizumab in patients suffering from haemophilia A from the phase III study, HAVEN. Meanwhile, studies showed ...
    07/27/2017 - 11:21 pm | View Link
  • Roche : Phase III ALUR study supports the use of Roche's Alecensa for people with advanced ALK-positive lung cancer
    Basel - Phase III ALUR study supports the use of Roche's Alecensa for people with advanced ALK-positive lung cancer * Results from the global ... health authorities as we seek to bring Alecensa to patients faster." Alecensa received conditional marketing ...
    03/3/2017 - 9:44 pm | View Link
  • NHS patients barred from BMS' Opdivo, Roche's Kadcyla
    NICE is planning to bar patients with a particular form of lung cancer from access to Bristol-Myers Squibb’s ground-breaking immunotherapy Opdivo on the ... the Early Access to Medicines Scheme. The drug’s innovative mode of action works by harnessing ...
    12/15/2015 - 5:45 pm | View Link
  • More
  • AstraZeneca PLC
    AstraZeneca PLC stock price, stock quotes and financial overviews from MarketWatch.
    03/18/2018 - 7:01 pm | View Website
  • 2017 Annual Report: Top 10 Pipelines | PharmaLive
    There was a significant drop-off in NME approvals by FDA in 2016, but there were not enough new drug applications with user fee goals to reach the lofty 2015 total.
    03/18/2018 - 4:45 pm | View Website
    Latest news from AFSPA on Federal Employees Health. March 7, 2018 Trogarzo Approved for HIV . On March 6, 2018, Theratechnologies and TaiMed Biologics received approval from the U.S. Food and Drug Administration (FDA) for Trogarzo™ (ibalizumab-uiyk) for use in combination with other antiretroviral therapies for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily ...
    03/18/2018 - 4:16 pm | View Website
  • AMGN Stock Price & News
    View the latest AMGN stock price with Barron's. Including historical share prices, analysis, earnings, cash flow and market valuation for Amgen Inc.
    03/18/2018 - 2:29 pm | View Website
  • Sclerosis | Definition of Sclerosis by Merriam-Webster
    Define sclerosis: pathological hardening of tissue especially from overgrowth of fibrous tissue or increase in interstitial… — sclerosis in a sentence
    03/18/2018 - 1:28 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News